Abstract
Fabry disease is an inherited lysosomal storage disease caused by deficiency of alpha-galactosidase A. Enzyme replacement therapy for this multisystem progressive disease has been available only since 2001. We here report the first known successful pregnancy of a female patient receiving such therapy.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Enzyme Therapy
-
Fabry Disease / complications
-
Fabry Disease / therapy*
-
Female
-
Humans
-
Infant, Newborn
-
Isoenzymes / therapeutic use
-
Lysosomal Storage Diseases / complications
-
Lysosomal Storage Diseases / therapy
-
Male
-
Pregnancy
-
Pregnancy Complications*
-
Pregnancy Outcome
-
Recombinant Proteins
-
Treatment Outcome
-
alpha-Galactosidase / metabolism
-
alpha-Galactosidase / therapeutic use*
Substances
-
Isoenzymes
-
Recombinant Proteins
-
agalsidase alfa
-
alpha-Galactosidase